Filing Details
- Accession Number:
- 0001209191-16-121444
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-05-18 19:14:55
- Reporting Period:
- 2016-05-16
- Filing Date:
- 2016-05-18
- Accepted Time:
- 2016-05-18 19:14:55
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1435049 | Aduro Biotech Inc. | ADRO | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1635616 | G. Dirk Brockstedt | C/O Aduro Biotech, Inc. 626 Bancroft Way, 3C Berkeley CA 94710 | Sr. Vp Of Research And Dev. | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2016-05-16 | 905 | $8.20 | 12,000 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- The sales reported in this Form 4 were affected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 13, 2015.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.16 to $8.24, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- Includes 905 shares acquired by the Reporting Person under the Issuer's 2015 Employee Stock Purchase Plan on May 13, 2016.